Watch this presentation by Thomas Modine for EuroPCR 2022 to hear about the multimodality approach to optimise TAVI procedure and its impact on post-operative course, to get an update on how minimalist TAVI can be performed successfully in most patients without conversion to general anaesthesia, and...

Join this discussion recorded in the PCR Live studio in London, where Sam Dawkins and Wolfgang Rottbauer, hosted by Jörg Hausleiter, talk about some new studies and clinical trials presented during PCR London Valves 2022. They also discuss the latest technologies available to treat mitral regurgitation.

View...

In this EuroPCR 2022 recording by Alison Duncan & Lenard Conradi, learn how to expand your mitral treatment options to include Tendyne TMVR therapy, understand the difference in patient management with the mitral standard of care, and optimise patient outcomes with Tendyne TMVR therapy through medical management best practices:...

Thanks to this interview between Enrique Gutierrez Ibanez and Nicolas Meneveau shot for EuroPCR 2022, be aware of the clinical evidence and the studies currently ongoing for the “coronary artery disease and aortic stenosis” clinical setting, learn more about the current approach to diagnose and treat...

Through this discussion between Yohei Ohno, Kendra Grubb, and Stefan James recorded for EuroPCR 2022, discover recent updates on the COT experience/studies (optimize PRO 400pts, OCEAN TAVI, personal experience), find out about key success factors/steps on the technique to achieve optimal results, and learn how to...

Follow this dialogue between Jochen Reinöhl and David Cohen, recorded for EuroPCR 2022, to find out more about clinical research: what exactly is the definition? What are the current challenges in conducting clinical research? How to ensure the participation of a diverse population? All the answers...

Elad Asher provides his take on this phase IIb trial in healthy people ages 50 to 80 showing that the novel intravenous treatment bentracimab significantly restored platelet function in patients receiving oral P2Y12 inhibitor ticagrelor. The clinical trial was presented by Deepak L. Bhatt at the American College of Cardiology...

Waqar Ahmed provides his take on the FLASH Mechanical Thrombectomy Registry which was presented by Catalin Toma at TCT 2022.

The article was simultaneously published in the EuroIntervention Journal: Acute Outcomes for the Full US Cohort of the FLASH Mechanical Thrombectomy Registry in Pulmonary Embolism. EuroIntervention, C. Toma et al. DOI:...

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

We are proud to celebrate the International Day for Interventional Cardiology, established by a resolution of the United Nations in September 2022 to raise public awareness of cardiovascular diseases and procedures, related complications as well as prevention and care. The resolution notes that interventional cardio-angiology improves health,...

Watch this presentation of the CHOICE CLOSURE trial proposed by Mohamed Abdel-Wahab for EuroPCR 2022 to understand the benefits of suture-based strategy in terms of access-site or access-related major and minor vascular complications, to compare suture-based to plug-based closure in large-bore arterial access, and to analyze...

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Pamela Gatto interviews Volkmar Falk, Cardiovascular Surgeon, and Dejan Milasinovic, Interventional Cardiologist, to get their perspective about the results of the REVIVED-BCIS2 trial.

The 3 questions are:

1. What were your first thoughts and feelings when the findings from REVIVED were presented at ESC 2022?
2. In STICH(es), CABG had a...

Thirty years after the first radial access interventional coronary procedure the RTC trial provides evidence that radial access for coronary angiography or PCI is associated with lower risks of all-cause death and bleeding compared with femoral access. Mirvat Alasnag interviews Giuseppe Gargiulo regarding the methodology and...

Ali Nazmi Calik asks trial investigator John Alexander about the design and results of the PACIFIC-AMI phase 2 trial, which revealed no increase in bleeding versus placebo.

Luigi Biasco interviews Scott Lim and Konstantinos P. Koulogiannis, Principal Investigators of CLASP IID.

The trial demonstrated safety and effectiveness of the PASCAL system and met non-inferiority endpoints, expanding transcatheter treatment options for prohibitive surgical risk patients with significant symptomatic degenerative mitral regurgitation.

Watch the replay of #AfricaPCR 2022’s live webinar on STEMI.

Coordinator:Stephen Worthley

Interventional cardiologist / Cardiologist

Macquarie University Hospital - Sydney, Australia